Top Pharmaceutical Stocks To Add to Your Watchlist - March 9th

Key Points

• Eli Lilly, AbbVie, and Abbott Laboratories are MarketBeat's top pharmaceutical stocks to watch today, selected by the stock screener for having the highest dollar trading volume among pharmaceutical names in recent days.
• Pharmaceutical stocks typically involve high R&D and regulatory risk but can deliver large upside from successful drug approvals and are highly sensitive to patent expirations, pricing pressure, and clinical-trial outcomes.
• The report highlights product exposure: Eli Lilly for diabetes and obesity drugs (Mounjaro, Trulicity, Jardiance, Zepbound), AbbVie for immunology and oncology blockbusters (Humira, Skyrizi, Rinvoq, Venclexta), and Abbott for diagnostics, medical devices, nutrition, and generics.

Eli Lilly and Company, AbbVie, and Abbott Laboratories are the three Pharmaceutical stocks to watch today, according to MarketBeat's stock screener tool. Pharmaceutical stocks are shares of publicly traded companies involved in discovering, developing, manufacturing, and selling prescription drugs, vaccines, and related therapies (often including biotechnology and generic-drug firms). For investors they typically mean exposure to high R&D and regulatory risk, potential for large upside from successful drugs or approvals, and sensitivity to patent expirations, pricing pressure, and clinical-trial outcomes. These companies had the highest dollar trading volume of any Pharmaceutical stocks within the last several days.

Eli Lilly and Company (LLY)

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity.

Read Our Latest Research Report on LLY

AbbVie (ABBV)

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers.

Read Our Latest Research Report on ABBV

Abbott Laboratories (ABT)

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon.

Read Our Latest Research Report on ABT

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.